BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Maryam Alimirah, Omar Sadiq, Stuart C. Gordon. Novel Therapies in Hepatic EncephalopathyClinics in Liver Disease 2020; 24(2): 303 doi: 10.1016/j.cld.2020.01.009
2
Michele Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Valentina Colonna, Masa Messano, Aleardo Koverech, Sergio Neri, Marco Vacante, Lisa Cammalleri, Massimo Motta. Acetyl l-carnitine (ALC) treatment in elderly patients with fatigueArchives of Gerontology and Geriatrics 2008; 46(2): 181 doi: 10.1016/j.archger.2007.03.012
3
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled TrialsArchives of Medical Research 2020; 51(1): 82 doi: 10.1016/j.arcmed.2019.12.005
4
Mariano Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Marco Vacante, Corrado Risino, Lisa Cammalleri, Giovanni Pennisi, Liborio Rampello. Acetyl-l-Carnitine Treatment in Minimal Hepatic EncephalopathyDigestive Diseases and Sciences 2008; 53(11): 3018 doi: 10.1007/s10620-008-0238-6
5
Tanja Burkard, Annette Biedermann, Christoph Herold, Michael Dietlein, Markus Rauch, Martin Diefenbach. Treatment with a potassium–iron–phosphate–citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathyEuropean Journal of Gastroenterology & Hepatology 2013; 25(3): 352 doi: 10.1097/MEG.0b013e32835afaa5
6
Michele Malaguarnera, Marco Vacante, Massimo Motta, Maria Giordano, Giulia Malaguarnera, Rita Bella, Giuseppe Nunnari, Liborio Rampello, Giovanni Pennisi. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trialMetabolic Brain Disease 2011; 26(4): 281 doi: 10.1007/s11011-011-9260-z
7
N. M. BASS. Review article: the current pharmacological therapies for hepatic encephalopathyAlimentary Pharmacology & Therapeutics 2007; 25: 23 doi: 10.1111/j.1746-6342.2006.03218.x
8
Yasuhiro Takikawa, Hidekatsu Kuroda, Kei Sawara. The Liver in Systemic Diseases2016; : 51 doi: 10.1007/978-4-431-55790-6_4
9
Non-absorbable disaccharides and antibacterials are the treatment of choice for hepatic encephalopathyDrugs & Therapy Perspectives 2011; 27(6): 17 doi: 10.2165/11206630-000000000-00000
10
Makoto Shiraki, Masahito Shimizu, Hisataka Moriwaki, Kiwamu Okita, Kazuhiko Koike. Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patientsHepatology Research 2017; 47(4): 321 doi: 10.1111/hepr.12750
11
Roger F. Butterworth. Metabolic Encephalopathy2009; : 149 doi: 10.1007/978-0-387-79112-8_9
12
Ting Wang, Kazuyuki Suzuki, Keisuke Kakisaka, Mio Onodera, Kei Sawara, Yasuhiro Takikawa. L‐carnitine prevents ammonia‐induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytesJournal of Gastroenterology and Hepatology 2019; 34(7): 1249 doi: 10.1111/jgh.14497
13
Chathur Acharya, Jasmohan S. Bajaj. Current Management of Hepatic EncephalopathyAmerican Journal of Gastroenterology 2018; 113(11): 1600 doi: 10.1038/s41395-018-0179-4
14
Longfa Kou, Rui Sun, Vadivel Ganapathy, Qing Yao, Ruijie Chen. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5)Expert Opinion on Therapeutic Targets 2018; 22(8): 715 doi: 10.1080/14728222.2018.1502273
15
Mariano Malaguarnera, Giovanni Pistone, Marinella Astuto, Ignazio Vecchio, Rocco Raffaele, Emilia Lo Giudice, Liborio Rampello. Effects of l-Acetylcarnitine on Cirrhotic Patients with Hepatic Coma: Randomized Double-Blind, Placebo-Controlled TrialDigestive Diseases and Sciences 2006; 51(12): 2242 doi: 10.1007/s10620-006-9187-0
16
Hisamitsu Miyaaki, Hironori Kobayashi, Satoshi Miuma, Masanori Fukusima, Ryu Sasaki, Masafumi Haraguchi, Kazuhiko Nakao. Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patientsBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01190-6
17
Thomas Bøhmer, Anne Bøen, Siv Cathrine Høymork. Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamineScandinavian Journal of Gastroenterology 2010; 45(6): 762 doi: 10.3109/00365521003624169
18
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Kouichi Gondo, Yu Asano, Nobuhiro Hattori, Nobuharu Tamaki, Shoko Suzuki, Yutaka Yasui, Takanori Hosokawa, Jun Itakura, Yuka Takahashi, Namiki Izumi. L-carnitine Reduces Muscle Cramps in Patients With CirrhosisClinical Gastroenterology and Hepatology 2015; 13(8): 1540 doi: 10.1016/j.cgh.2014.12.005
19
Nicolas Weiss, Pierre Barbier Saint Hilaire, Benoit Colsch, Foucauld Isnard, Suleiman Attala, Augustin Schaefer, Maria del Mar Amador, Marika Rudler, Foudil Lamari, Frédéric Sedel, Dominique Thabut, Christophe Junot. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathyJournal of Hepatology 2016; 65(6): 1120 doi: 10.1016/j.jhep.2016.07.046
20
Zdravka Zafirova, Michael OʼConnor. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failureCurrent Opinion in Anaesthesiology 2010; 23(2): 121 doi: 10.1097/ACO.0b013e32833724c3
21
Qian Jiang, Gang Jiang, Ke-qing Shi, Hong Cai, Yi-xin Wang, Ming-hua Zheng. Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicineAnnals of Hepatology 2013; 12(5): 803 doi: 10.1016/S1665-2681(19)31323-7
22
Kazuyuki Suzuki, Mio Onodera, Keisuke Kakisaka, Kei Endo, Kei Sawara, Kanta Oikawa, Ting Wang, Ryujin Endo, Yasuhiro Takikawa. Serum free fatty acid concentration as a surrogate marker for serum carnitine status in patients with liver cirrhosisKanzo 2013; 54(11): 796 doi: 10.2957/kanzo.54.796
23
Mariano Malaguarnera, Rita Bella, Marco Vacante, Maria Giordano, Giulia Malaguarnera, Maria Pia Gargante, Massimo Motta, Antonio Mistretta, Liborio Rampello, Giovanni Pennisi. Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathyScandinavian Journal of Gastroenterology 2011; 46(6): 750 doi: 10.3109/00365521.2011.565067
24
Shunsuke Tsubata, Kohei Ogawa, Masaaki Hirano, Akira Sakamaki, Yukio Aruga, Masashi Yamakawa. Experience using levocarnitine chloride in treatment of hepatic encephalopathyKanzo 2014; 55(1): 76 doi: 10.2957/kanzo.55.76
25
Marsha Y. Morgan, A. Blei, K. Grüngreiff, R. Jalan, G. Kircheis, G. Marchesini, O. Riggio, Karin Weissenborn. The treatment of hepatic encephalopathyMetabolic Brain Disease 2007; 22(3-4): 389 doi: 10.1007/s11011-007-9060-7
26
Eric Monnet, Lisa Klopp, Angela J. Marolf, Eric Monnet, Craig B. Webb, Ronald Bright, Daniel D. Smeak. Small Animal Soft Tissue Surgery2014; : 407 doi: 10.1002/9781118997505.ch43
27
Roger F. Butterworth. Alcohol and the Nervous SystemHandbook of Clinical Neurology 2014; 125: 589 doi: 10.1016/B978-0-444-62619-6.00034-3
28
Miroslav Cuturic, Ruth K. Abramson, Robert R. Moran, James W. Hardin, Elaine M. Frank, Andrea A. Sellers. Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patientsNeurological Sciences 2013; 34(1): 93 doi: 10.1007/s10072-012-0952-x
29
Michele Malaguarnera, Marco Vacante, Maria Giordano, Giovanni Pennisi, Rita Bella, Liborio Rampello, Mariano Malaguarnera, Giovanni Li Volti, Fabio Galvano. Oral acetyl-l-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled studyThe American Journal of Clinical Nutrition 2011; 93(4): 799 doi: 10.3945/ajcn.110.007393
30
Eugeniy S. Protasov, Daria V. Borsakova, Yuliya G. Alexandrovich, Anatoliy V. Korotkov, Elena A. Kosenko, Andrey A. Butylin, Fazoil I. Ataullakhanov, Elena I. Sinauridze. Erythrocytes as bioreactors to decrease excess ammonium concentration in bloodScientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37828-5
31
Bojana Marković-Živković, Goran Bjelaković, Danica Marković, Dušica Stojanović. NUTRITIVNA TERAPIJA HEPATIČNE ENCEFALOPATIJE KAO KOMPLIKACIJE CIROZE JETREActa medica medianae 2013; : 39 doi: 10.5633/amm.2012.0208s
32
Akram Jamshidzadeh, Hossein Niknahad, Reza Heidari, Mahdi Zarei, Mohammad Mehdi Ommati, Forouzan Khodaei. Carnosine protects brain mitochondria under hyperammonemic conditions: Relevance to hepatic encephalopathy treatmentPharmaNutrition 2017; 5(2): 58 doi: 10.1016/j.phanu.2017.02.004
33
Peter Ferenci, Christian Müller. Evidence‐Based Gastroenterology and Hepatology2010; : 636 doi: 10.1002/9781444314403.ch39
34
Tatsunori Hanai, Makoto Shiraki, Kenji Imai, Atsushi Suetugu, Koji Takai, Masahito Shimizu. Usefulness of Carnitine Supplementation for the Complications of Liver CirrhosisNutrients 2020; 12(7): 1915 doi: 10.3390/nu12071915
35
Yasuhiro Takikawa, Takuro Sato, Keisuke Kakisaka. The Evolving Landscape of Liver Cirrhosis Management2019; : 93 doi: 10.1007/978-981-13-7979-6_8
36
Yan-Yan Jia, Cheng-Tao Lu, Juan Feng, Ying Song, Jin-Yi Zhao, Shan Wang, Yuan Sun, Ai-Dong Wen, Zhi-Fu Yang, Tai-Jun Hang. Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir DipivoxilBasic & Clinical Pharmacology & Toxicology 2013; 113(6): 431 doi: 10.1111/bcpt.12112
37
Nader Dbouk, Brendan M. McGuire. Hepatic encephalopathy: A review of its pathophysiology and treatmentCurrent Treatment Options in Gastroenterology 2006; 9(6): 464 doi: 10.1007/s11938-006-0003-x
38
A. Hagerman, O. Karam. Molecular Adsorbent Recirculating System (MARS™ en réanimation pédiatriqueRéanimation 2016; 25(2): 239 doi: 10.1007/s13546-015-1162-3
39
Zakraus K. Mahdavi, Ram Narayan, Shraddha Mainali, Benjamin M. Greenberg, Venkatesh Aiyagari, David L. McDonagh. A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement UseNeurocritical Care 2018; 29(3): 504 doi: 10.1007/s12028-017-0473-9
40
Kazuto TAJIRI, Yuka FUTSUKAICHI, Saito KOBAYASHI, Satoshi YASUMURA, Terumi TAKAHARA, Masami MINEMURA, Toshiro SUGIYAMA. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver CirrhosisJournal of Nutritional Science and Vitaminology 2018; 64(5): 321 doi: 10.3177/jnsv.64.321
41
Berkeley N. Limketkai, Stephen D. Zucker. Hyperammonemic Encephalopathy Caused by Carnitine DeficiencyJournal of General Internal Medicine 2008; 23(2): 210 doi: 10.1007/s11606-007-0473-0
42
Arturo J Martí-Carvajal, Christian Gluud, Ingrid Arevalo-Rodriguez. Acetyl-L-carnitine for patients with hepatic encephalopathyCochrane Database of Systematic Reviews 2014;  doi: 10.1002/14651858.CD011451
43
Marsha Y. Morgan. Sherlock's Diseases of the Liver and Biliary System2011; : 121 doi: 10.1002/9781444341294.ch8
44
Na Xu, Shicui Zhang. Identification, expression and bioactivity of a chitotriosidase-like homolog in amphioxus: Dependence of enzymatic and antifungal activities on the chitin-binding domainMolecular Immunology 2012; 51(1): 57 doi: 10.1016/j.molimm.2012.02.003
45
Hwayoung Lee, Hyung-Ki Kim, Jun-Tack Kwon, Shohyun Park, Hae Jeong Park, Su Kang Kim, Jin Kyung Park, Won Sub Kang, Young Jong Kim, Joo-Ho Chung, Jong Woo Kim, Hak-Jae Kim. BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophreniaPsychiatry Research 2018; 259: 197 doi: 10.1016/j.psychres.2017.10.018
46
Mariano Malaguarnera, Corrado Risino, Lisa Cammalleri, Lucia Malaguarnera, Marinella Astuto, Ignazio Vecchio, Liborio Rampello. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind studyEuropean Journal of Gastroenterology & Hepatology 2009; 21(7): 762 doi: 10.1097/MEG.0b013e328309c791
47
C F Rose. Ammonia-Lowering Strategies for the Treatment of Hepatic EncephalopathyClinical Pharmacology & Therapeutics 2012; 92(3): 321 doi: 10.1038/clpt.2012.112
48
Piero Amodio. Cirrhosis: A practical guide to management2015; : 105 doi: 10.1002/9781118412640.ch11
49
Piero Amodio. Hepatic encephalopathy: Diagnosis and managementLiver International 2018; 38(6): 966 doi: 10.1111/liv.13752
50
Michael Bismuth, Natalie Funakoshi, Jean-François Cadranel, Pierre Blanc. Hepatic encephalopathyEuropean Journal of Gastroenterology & Hepatology 2011; 23(1): 8 doi: 10.1097/MEG.0b013e3283417567
51
Naoto Fujiwara, Hayato Nakagawa, Kenichiro Enooku, Yotaro Kudo, Yuki Hayata, Takuma Nakatsuka, Yasuo Tanaka, Ryosuke Tateishi, Yohko Hikiba, Kento Misumi, Mariko Tanaka, Akimasa Hayashi, Junji Shibahara, Masashi Fukayama, Junichi Arita, Kiyoshi Hasegawa, Hadassa Hirschfield, Yujin Hoshida, Yoshihiro Hirata, Motoyuki Otsuka, Keisuke Tateishi, Kazuhiko Koike. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesityGut 2018; 67(8): 1493 doi: 10.1136/gutjnl-2017-315193
52
Paula V. Phongsamran, Jiwon W. Kim, Jennifer Cupo Abbott, Angela Rosenblatt. Pharmacotherapy for Hepatic EncephalopathyDrugs 2010; 70(9): 1131 doi: 10.2165/10898630-000000000-00000
53
Nathan J. Shores, Emmet B. Keeffe. Is Oral l-Acyl-Carnitine an Effective Therapy for Hepatic Encephalopathy? Review of the LiteratureDigestive Diseases and Sciences 2008; 53(9): 2330 doi: 10.1007/s10620-007-0183-9
54
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complicationsClinical and Molecular Hepatology 2020; 26(2): 83 doi: 10.3350/cmh.2019.0010n
55
Vinay Sundaram, Obaid S. Shaikh. Hepatic Encephalopathy: Pathophysiology and Emerging TherapiesMedical Clinics of North America 2009; 93(4): 819 doi: 10.1016/j.mcna.2009.03.009
56
Amir Abbasnezhad, Razieh Choghakhori, Sara Kashkooli, Meysam Alipour, Omid Asbaghi, Rasool Mohammadi. Effect of L‐carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta‐analysisJournal of Gastroenterology and Hepatology 2019; 34(12): 2062 doi: 10.1111/jgh.14765